End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-14 EDT
|
5-day change
|
1st Jan Change
|
7.84
CNY
|
+0.90%
|
|
+3.16%
|
-38.27%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
2,197
|
1,454
|
1,968
|
1,984
|
2,332
|
1,909
|
Enterprise Value (EV)
1 |
2,795
|
2,067
|
2,368
|
2,265
|
2,454
|
2,253
|
P/E ratio
|
214
x
|
165
x
|
53.6
x
|
-84.4
x
|
9.93
x
|
-50
x
|
Yield
|
0.13%
|
0.4%
|
0.45%
|
-
|
-
|
-
|
Capitalization / Revenue
|
8.14
x
|
5.85
x
|
4.7
x
|
18.1
x
|
9.24
x
|
2.99
x
|
EV / Revenue
|
10.4
x
|
8.32
x
|
5.65
x
|
20.7
x
|
9.73
x
|
3.53
x
|
EV / EBITDA
|
85.7
x
|
70.1
x
|
22.5
x
|
-140
x
|
-145
x
|
170
x
|
EV / FCF
|
49.8
x
|
-1,184
x
|
20.7
x
|
-10.7
x
|
-9.33
x
|
3.8
x
|
FCF Yield
|
2.01%
|
-0.08%
|
4.83%
|
-9.36%
|
-10.7%
|
26.3%
|
Price to Book
|
3.57
x
|
1.71
x
|
2.02
x
|
2.1
x
|
1.98
x
|
1.57
x
|
Nbr of stocks (in thousands)
|
146,842
|
146,842
|
146,842
|
146,842
|
146,842
|
146,842
|
Reference price
2 |
14.96
|
9.900
|
13.40
|
13.51
|
15.88
|
13.00
|
Announcement Date
|
18-04-24
|
19-04-24
|
20-04-24
|
21-04-27
|
22-04-29
|
23-04-27
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
270
|
248.5
|
418.9
|
109.6
|
252.3
|
638.6
|
EBITDA
1 |
32.6
|
29.49
|
105.2
|
-16.21
|
-16.92
|
13.23
|
EBIT
1 |
30.26
|
27.03
|
101.1
|
-24.95
|
-45.41
|
-16.04
|
Operating Margin
|
11.21%
|
10.88%
|
24.13%
|
-22.77%
|
-18%
|
-2.51%
|
Earnings before Tax (EBT)
1 |
21.48
|
16.43
|
94.15
|
-21.11
|
391.1
|
-17.66
|
Net income
1 |
10.38
|
8.828
|
36.65
|
-23.18
|
235.6
|
-37.93
|
Net margin
|
3.85%
|
3.55%
|
8.75%
|
-21.15%
|
93.4%
|
-5.94%
|
EPS
2 |
0.0700
|
0.0600
|
0.2500
|
-0.1600
|
1.600
|
-0.2600
|
Free Cash Flow
1 |
56.13
|
-1.746
|
114.4
|
-212
|
-263.2
|
593.3
|
FCF margin
|
20.79%
|
-0.7%
|
27.31%
|
-193.43%
|
-104.32%
|
92.91%
|
FCF Conversion (EBITDA)
|
172.17%
|
-
|
108.78%
|
-
|
-
|
4,484.99%
|
FCF Conversion (Net income)
|
540.56%
|
-
|
312.17%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0200
|
0.0400
|
0.0600
|
-
|
-
|
-
|
Announcement Date
|
18-04-24
|
19-04-24
|
20-04-24
|
21-04-27
|
22-04-29
|
23-04-27
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
598
|
613
|
400
|
281
|
122
|
344
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
18.34
x
|
20.81
x
|
3.804
x
|
-17.34
x
|
-7.233
x
|
26
x
|
Free Cash Flow
1 |
56.1
|
-1.75
|
114
|
-212
|
-263
|
593
|
ROE (net income / shareholders' equity)
|
2.01%
|
1.33%
|
4.1%
|
-2.17%
|
19.3%
|
-2.41%
|
ROA (Net income/ Total Assets)
|
0.88%
|
0.67%
|
2.28%
|
-0.58%
|
-0.88%
|
-0.32%
|
Assets
1 |
1,177
|
1,327
|
1,605
|
3,964
|
-26,840
|
11,682
|
Book Value Per Share
2 |
4.190
|
5.780
|
6.640
|
6.430
|
8.030
|
8.300
|
Cash Flow per Share
2 |
1.620
|
3.400
|
1.970
|
0.4500
|
3.270
|
0.0900
|
Capex
1 |
0.88
|
1.16
|
0.33
|
0.14
|
2.12
|
2.82
|
Capex / Sales
|
0.32%
|
0.47%
|
0.08%
|
0.13%
|
0.84%
|
0.44%
|
Announcement Date
|
18-04-24
|
19-04-24
|
20-04-24
|
21-04-27
|
22-04-29
|
23-04-27
|
|
1st Jan change
|
Capi.
|
---|
| -38.27% | 159M | | -1.28% | 9.57B | | +1.29% | 1.48B | | -9.38% | 1.15B | | -17.43% | 869M | | -1.00% | 474M | | +2.83% | 440M | | -47.78% | 379M | | -22.36% | 344M | | -3.26% | 215M |
Medical Equipment Wholesale
|